Program in Translational and Experimental Hematology

转化和实验血液学项目

• 批准号: 10443647
• 负责人: Ravindra Majeti
• 金额: $ 33.31万
• 依托单位: STANFORD UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-07-01 至 2024-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10443647
• 关键词: Experimental Hematology; programs

Benign and malignant blood diseases cause major morbidity and mortality in the US and are rising in prevalence due to the rapid aging of the American population. Effective therapies are rare in part because of an insufficient number of physician-scientists and PhD scientists trained in Hematology research. Our Training Program in Translational and Experimental Hematology addresses this important problem by supporting the training of investigators in basic science or translational research in Hematology. We have designed a Training Program with rigorous research opportunities and close mentoring by faculty. Our Program provides an outstanding panel of leading experts in Hematology as Program Faculty to direct fellows in their research endeavors. Physician- scientists enter the T32 Training Program after clinical training in adult Hematology. PhD fellows enter the Program directly from the laboratories of Program Faculty through a competitive process. Physician-scientists interested in translational research and clinical investigation have the option of pursuing a Master’s Degree in Clinical Epidemiology to acquire skills in the design of clinical trials. Fellows in the T32 Program receive training in three broad areas of hematology research: hematopoiesis and stem cell biology; thrombosis and vascular biology; and immunology and immunotherapy. Research in the Training Program comprises two years and is enhanced by didactic lectures, outstanding seminar series and a rich scientific environment. This Training Program in Translational and Experimental Hematology contributes new biological insights, novel means of prevention and new therapies for blood disorders through postdoctoral training of fellows in Hematology research and by preparing future investigators for careers in research in Hematology.

在美国，良性和恶性血液疾病导致主要的发病率和死亡率， 由于美国人口的迅速老龄化，有效 治疗是罕见的，部分原因是医生，科学家的数量不足， 在血液学研究中接受过培训的博士科学家。我们的翻译培训计划 和实验血液学解决这一重要问题，支持 培训基础科学或血液学转化研究的研究者。我们 设计了一个培训计划，提供严格的研究机会， 由教师指导。我们的计划提供了一个杰出的专家小组， 血液学作为项目教师指导研究员的研究工作。医生- 科学家在成人血液学临床培训后进入T32培训计划。博士 研究员直接从项目学院的实验室通过一个 竞争过程。对转化研究和临床研究感兴趣的医生-科学家 调查有追求硕士学位的临床流行病学的选择， 获得临床试验设计的技能。T32计划的研究员接受培训 在血液学研究的三个广泛领域：造血和干细胞生物学; 血栓形成和血管生物学;以及免疫学和免疫疗法。的研究 培训计划为期两年，并通过教学讲座得到加强， 研讨会系列和丰富的科学环境。翻译培训计划 和实验血液学贡献了新的生物学见解，新的手段， 通过博士后研究员培训预防和治疗血液病的新方法 在血液学研究，并准备未来的研究人员在研究的职业生涯， 血液学。